• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA Finally Updates IVD Reagent Classification

NMPA Finally Updates IVD Reagent Classification

Tuesday, 24 November 2020 / Published in Medical Device, News, NMPA Registration in China

NMPA Finally Updates IVD Reagent Classification

On October 10, the NMPA (National Medical Products Administration) announced (No. 112 of 2020) an update to the product information of 29 IVD reagents in the 6840 Classified Subdirectory (2013 Version):
– A total of 29 reagent products (28 test reagents and 1 reagent for blood cell removal) were reclassified from class III to class II
– The product description / intended use of the 29 products were redefined
– The mentioned changes took effect on October 10 after the announcement

The 29 reclassified products include kappa light chain test kits, lambda light chain test kits, blood-derived cell removal reagents, and also test kits for tumors and cancer diseases.

Back in April 2020, the NMPA had already proposed the amendments of these 29 products, but made slight adjustments to the product descriptions after reviewing the comments from the public consultation. (Read our previous article about the draft proposal)

The current classification catalogue for IVD reagents dates to 2013. Therefore, NMPA’s recent release of the updated product information of 29 IVD reagents, primarily to down-classify from class III to class II, was long overdue.

 By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: IVD, IVD reagents, test kits

What you can read next

UDI Now Proposed for All Class III Medical Devices and IVDs
Cisema Expands China Footprint with New Offices in Tianjin and Jinan
Chinese Pharmacopoeia 2020
Chinese Pharmacopoeia 2020 edition – official English translation issued in March 2023

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Clinical trials of sodium hyaluronate complex solution

    Clinical trials of sodium hyaluronate complex solution – draft guidelines issued

    Clinical trials of sodium hyaluronate complex s...
  • China registration of ophthalmic optical measurement devices

    China registration of ophthalmic optical measurement devices – Technical review guidelines issued

    China registration of ophthalmic optical measur...
  • Pre-communication for Hainan medical device clinical RWD

    Pre-communication for Hainan medical device clinical RWD application – Trial measures implemented

    Pre-communication for Hainan medical device cli...
  • Registration platform for cosmetic raw materials safety information

    Registration platform for cosmetic raw materials safety information – Draft guidelines issued

    The registration platform for cosmetic raw mate...
  • Technical guidelines for reporting cosmetics formulas

    Technical guidelines for reporting cosmetics formulas – draft issued

    Technical guidelines for reporting cosmetics fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP